Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
Director departure
Merger agrmnt [a]
Appointed director
|
|
Foamix Pharmaceuticals Ltd. (FOMX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/18/2020 |
4
| STERN STANLEY (Director) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Disposed/sold 21,147 shares
@ $0
Disposed/sold 21,212 shares
@ $0
Disposed/sold 27,000 options
@ $5.88, valued at
$158.8k
Disposed/sold 21,562 options
@ $4.76, valued at
$102.6k
Disposed/sold 24,947 options
@ $5.06, valued at
$126.2k
Disposed/sold 12,719 options
@ $3.53, valued at
$44.9k
|
|
| 03/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2020 |
4
| Stuart Iain (Chief Scientific Officer) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Disposed/sold 12,333 shares
@ $0
Disposed/sold 91,303 shares
@ $0
Disposed/sold 40,000 options
@ $8.54, valued at
$341.6k
Disposed/sold 13,000 options
@ $5.39, valued at
$70.1k
Disposed/sold 30,000 options
@ $6.35, valued at
$190.5k
Disposed/sold 75,997 options
@ $3.77, valued at
$286.5k
Disposed/sold 96,365 options
@ $4.03, valued at
$388.4k
|
|
| 03/11/2020 |
4
| Schwartz Aharon (Director) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Disposed/sold 112,200 shares
@ $0
Disposed/sold 24,000 options
@ $11.8687, valued at
$284.8k
Disposed/sold 21,435 options
@ $4.687, valued at
$100.5k
Disposed/sold 24,883 options
@ $5.022, valued at
$125k
Disposed/sold 49,412 options
@ $2.66, valued at
$131.4k
Disposed/sold 38,156 options
@ $3.53, valued at
$134.7k
|
|
| 03/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2020 |
4
| Hirsch Stanley (Director) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Disposed/sold 52,842 shares
@ $0
Disposed/sold 182,500 shares
@ $0
Disposed/sold 59,016 shares
@ $0
Disposed/sold 27,000 options
@ $5.88, valued at
$158.8k
Disposed/sold 82,153 options
@ $4.69, valued at
$385.3k
Disposed/sold 49,766 options
@ $5.02, valued at
$249.8k
|
|
| 03/11/2020 |
4
| Harsch Mutya (CLO and General Counsel) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Disposed/sold 12,742 shares
@ $0
Disposed/sold 85,490 shares
@ $0
Disposed/sold 50,000 options
@ $6.35, valued at
$317.5k
Disposed/sold 70,297 options
@ $3.77, valued at
$265k
Disposed/sold 96,365 options
@ $4.03, valued at
$388.4k
|
|
| 03/11/2020 |
4
| Hadar Ilan (CFO & Country Manager) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Disposed/sold 14,077 shares
@ $0
Disposed/sold 116,501 shares
@ $0
Disposed/sold 5,469 options
@ $1.92, valued at
$10.5k
Disposed/sold 24,125 options
@ $5.46, valued at
$131.7k
Disposed/sold 18,000 options
@ $6.77, valued at
$121.9k
Disposed/sold 202,004 options
@ $7.13, valued at
$1.4M
Disposed/sold 60,000 options
@ $6.34, valued at
$380.4k
Disposed/sold 60,389 options
@ $10.31, valued at
$622.6k
Disposed/sold 196,205 options
@ $5.22, valued at
$1M
Disposed/sold 35,093 options
@ $6.4, valued at
$224.6k
Disposed/sold 94,996 options
@ $3.81, valued at
$361.9k
|
|
| 03/11/2020 |
4
| Domzalski David (CEO) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Disposed/sold 90,902 shares
@ $0
Disposed/sold 233,126 shares
@ $0
Disposed/sold 18,750 options
@ $7.984, valued at
$149.7k
Disposed/sold 236,810 options
@ $7.14, valued at
$1.7M
Disposed/sold 60,000 options
@ $6.04, valued at
$362.4k
Disposed/sold 71,369 options
@ $10.218, valued at
$729.2k
Disposed/sold 327,720 options
@ $5.759, valued at
$1.9M
Disposed/sold 70,187 options
@ $5.06, valued at
$355.1k
Disposed/sold 170,993 options
@ $3.77, valued at
$644.6k
Disposed/sold 240,912 options
@ $4.03, valued at
$970.9k
|
|
| 03/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2020 |
4
| Bright Rex (Director) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Disposed/sold 27,000 options
@ $5.88, valued at
$158.8k
Disposed/sold 21,562 options
@ $4.76, valued at
$102.6k
Disposed/sold 24,947 options
@ $5.06, valued at
$126.2k
Disposed/sold 49,412 options
@ $2.66, valued at
$131.4k
Disposed/sold 38,156 options
@ $3.53, valued at
$134.7k
|
|
| 03/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Harsch Mutya (CLO and General Counsel) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Granted 1,761 shares
@ $2.6775, valued at
$4.7k
|
|
| 03/03/2020 |
4
| Domzalski David (CEO) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Granted 4,705 shares
@ $2.6775, valued at
$12.6k
|
|
| 03/03/2020 |
4
| STERN STANLEY (Director) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Granted 14,164 shares
@ $0
Granted 12,719 options to buy
@ $3.53, valued at
$44.9k
|
|
| 03/03/2020 |
4
| Schwartz Aharon (Director) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Granted 38,156 options to buy
@ $3.53, valued at
$134.7k
|
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Hirsch Stanley (Director) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Granted 42,493 shares
@ $0 |
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Bright Rex (Director) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Granted 38,156 options to buy
@ $3.53, valued at
$134.7k
|
|
| 02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2020 |
4
| Stuart Iain (Chief Scientific Officer) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Granted 41,299 shares
@ $0
Granted 96,365 options to buy
@ $4.03, valued at
$388.4k
|
|
| 02/24/2020 |
4
| Harsch Mutya (CLO and General Counsel) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Granted 41,299 shares
@ $0
Granted 96,365 options to buy
@ $4.03, valued at
$388.4k
|
|
| 02/24/2020 |
4
| Hadar Ilan (CFO & Country Manager) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Granted 41,299 shares
@ $0
Granted 96,365 options to buy
@ $4.03, valued at
$388.4k
|
|
| 02/24/2020 |
4
| Domzalski David (CEO) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Granted 103,248 shares
@ $0
Granted 240,912 options to buy
@ $4.03, valued at
$970.9k
|
|
| 01/03/2020 |
4
| Wiley Matthew T. (Chief Commercial Officer) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Paid exercise price by delivering 2,500 shares
@ $3.28, valued at
$8.2k
|
|
| 01/03/2020 |
4
| Stuart Iain (Chief Scientific Officer) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Paid exercise price by delivering 514 shares
@ $3.28, valued at
$1.7k
|
|
| 01/03/2020 |
4
| Harsch Mutya (CLO and General Counsel) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Paid exercise price by delivering 618 shares
@ $3.28, valued at
$2k
|
|
| 01/03/2020 |
4
| Domzalski David (CEO) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Paid exercise price by delivering 2,751 shares
@ $3.28, valued at
$9k
|
|
| 12/03/2019 |
4
| Domzalski David (CEO) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Granted 9,842 shares
@ $2.159, valued at
$21.2k
|
|
| 12/03/2019 |
4
| Wiley Matthew T. (Chief Commercial Officer) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Granted 9,842 shares
@ $2.159, valued at
$21.2k
|
|
| 12/03/2019 |
4
| Harsch Mutya (CLO and General Counsel) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Granted 4,284 shares
@ $2.159, valued at
$9.2k
|
|
| 11/05/2019 |
4
| Hirsch Stanley (Director) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Exercised 32,500 options
@ $0.62, valued at
$20.2k
|
|
|
|
|